Search research articles
Contact Us
Filters
Showing results (111-120 of 278) with videos related to
Page
of 28
Sort By:
Journal of the American Society of Nephrology : JASN
|
April 16, 2016
Proton Pump Inhibitors and CKD
Dennis G Moledina, Mark A Perazella
Kidney Research and Clinical Practice
|
July 10, 2019
Acute kidney injury in the patient with cancer
Mitchell H Rosner, Mark A Perazella
American Journal of Physiology. Renal Physiology
|
June 23, 2017
Harnessing basic and clinic tools to evaluate SGLT2 inhibitor nephrotoxicity
Danielle L Saly, Mark A Perazella
The New England Journal of Medicine
|
May 4, 2017
Acute Kidney Injury in Patients with Cancer
Mitchell H Rosner, Mark A Perazella
Kidney International
|
August 8, 2008
Bisphosphonate nephrotoxicity
Mark A Perazella, Glen S Markowitz
Kidney International Reports
|
August 11, 2020
Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events
Sandra M Herrmann, Mark A Perazella
Expert Review of Cardiovascular Therapy
|
May 14, 2005
Adverse cardiorenal effects of aldosterone: is aldosterone antagonism beneficial?
Steven G Coca, Mark A Perazella
Nature Reviews. Nephrology
|
May 8, 2013
Three feasible strategies to minimize kidney injury in 'incipient AKI'
Mark A Perazella, Steven G Coca
Drug Safety
|
December 3, 2014
Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment
Randy L Luciano, Mark A Perazella
Clinical Journal of the American Society of Nephrology : CJASN
|
August 16, 2015
Nephrologists as Educators: Clarifying Roles, Seizing Opportunities
Kenar D Jhaveri, Mark A Perazella
Page
of 28
Search research articles
Search
Showing results (111-120 of 278) with videos related to
Sort By:
Page
of 28
Journal of the American Society of Nephrology : JASN
|
April 16, 2016
Proton Pump Inhibitors and CKD
Dennis G Moledina, Mark A Perazella
Kidney Research and Clinical Practice
|
July 10, 2019
Acute kidney injury in the patient with cancer
Mitchell H Rosner, Mark A Perazella
American Journal of Physiology. Renal Physiology
|
June 23, 2017
Harnessing basic and clinic tools to evaluate SGLT2 inhibitor nephrotoxicity
Danielle L Saly, Mark A Perazella
The New England Journal of Medicine
|
May 4, 2017
Acute Kidney Injury in Patients with Cancer
Mitchell H Rosner, Mark A Perazella
Kidney International
|
August 8, 2008
Bisphosphonate nephrotoxicity
Mark A Perazella, Glen S Markowitz
Kidney International Reports
|
August 11, 2020
Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events
Sandra M Herrmann, Mark A Perazella
Expert Review of Cardiovascular Therapy
|
May 14, 2005
Adverse cardiorenal effects of aldosterone: is aldosterone antagonism beneficial?
Steven G Coca, Mark A Perazella
Nature Reviews. Nephrology
|
May 8, 2013
Three feasible strategies to minimize kidney injury in 'incipient AKI'
Mark A Perazella, Steven G Coca
Drug Safety
|
December 3, 2014
Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment
Randy L Luciano, Mark A Perazella
Clinical Journal of the American Society of Nephrology : CJASN
|
August 16, 2015
Nephrologists as Educators: Clarifying Roles, Seizing Opportunities
Kenar D Jhaveri, Mark A Perazella
Page
of 28